COVID-19 Webinars

COVID-19: The Invisible Impact on Dermatologists and Dermatology Practices

By May 7, 2020April 22nd, 2021No Comments

JDD Multimedia

COVID-19: The Invisible Impact on Dermatologists and Dermatology Practices

Join your dermatology colleagues and thought leaders as we examine the hidden impact of COVID-19 on dermatologists and providers, including new and small private practices, emotional wellbeing and the evolving priorities placed on providers during the global coronavirus pandemic. Panelists will discuss their first-hand, personal experience living with COVID-19 and ways it has impacted their physical and emotional health, practice and personal life.
Discussion and guidance will be given on simple steps you can take in the wellness sphere, crisis management and return to practice concepts for both large and small dermatology practices.

Moderators

  • Richard G. Fried, MD, PhD (Board Certified Dermatologist & Clinical Psychologist, Clinical Director, Yardley Dermatology Associates)

Panelists

  • Evan Rieder, MD (Board Certified Dermatologist & Psychiatrist, NYU Langone Health)
  • Paul Jarrod Frank, MD (Chief Medical Officer & Founder, PFRANKMD)
  • Melissa Kanchanapoomi Levin, MD (Founder, Entière Dermatology)

You May Also Like

Journal of Drugs in Dermatology JDD Article About The Multifaceted Effects of Berberine: Potential Uses in DermatologyFeatured ArticlesLatest NewsThe Latest
March 13, 2025

The Multifaceted Effects of Berberine: Potential Uses in Dermatology

Berberine in Dermatology: A Natural Ally for Complex Skin Conditions? Berberine, a plant-derived alkaloid long used in traditional medicine, is gaining traction as a complementary therapy in dermatology. With its…
Journal of Drugs in Dermatology JDD Article About Management of Acute Hematomas and Methods to Mitigate RiskFeatured ArticlesLatest NewsThe Latest
March 12, 2025

Management of Acute Hematomas and Methods to Mitigate Risk

Post-Surgical Bleeding in Dermatology: Risk, Management, and Intervention Postoperative bleeding is one of the most common complications in dermatologic surgery, potentially leading to hematoma formation and impaired healing. While careful…
Journal of Drugs in Dermatology JDD Article About Alopecia as an Adverse Event of Immune Checkpoint Inhibitor Therapies: Clinical Evidence and OutcomesAlopeciaFeatured ArticlesHairLatest NewsThe Latest
March 11, 2025

Alopecia as an Adverse Event of Immune Checkpoint Inhibitor Therapies: Clinical Evidence and Outcomes

ICI Therapy and Hair Loss: A Rare but Impactful Side Effect Immune checkpoint inhibitors (ICIs) have transformed cancer treatment, empowering the immune system to target tumors more effectively. But with…

Leave a Reply